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 Abstract 
Accurate measurement of brain metabolite concentrations with 1H-MRS can be problematic due to 
large voxels with mixed tissue composition, requiring adjustment for differing relaxation rates in 
each tissue if absolute concentration estimates are desired. Adjusting for tissue-specific metabolite 
signal relaxation, however, requires also knowing the relative gray (GM) and white matter (WM) 
concentrations of the metabolite within these compartments, which are not known a priori.  
Expressions for estimating the molality and molarity of brain metabolites with 1H-MRS are 
extended to account for tissue-specific relaxation of the metabolite signals and examined under 
different assumptions with simulated and real data. Though the modified equations have two 
unknowns and, hence, are unsolvable explicitly, they are nonetheless useful for estimating the effect 
of tissue-specific metabolite relaxation rates on concentration estimates under a range of 
assumptions and experimental parameters using simulated and real data. In simulated data using 
reported GM and WM T1 and T2 times for NAA at 3T and a hypothetical GM/WM NAA ratio, errors of  
6.5-7.8% in concentrations resulted when TR was 1.5 s and TE was 0.144s, but reduced to less than 
0.5% when TR was 6 s and TE was 0.006 s. In real data obtained at TR/TE=1.5/0.04s, the difference 
in the results (4%) was similar to that obtained with simulated data when assuming tissue-specific 
relaxation times rather than GM-WM averaged times. Using the expressions introduced in this 
report, these results can be extrapolated to any metabolite or set of assumptions regarding tissue-
specific relaxation. Furthermore, while serving to bound the problem, this work underscores the 
challenge of correcting for relaxation effects given that relaxation times are generally not known 
and impractical to measure in most studies. To minimize such effects, the data should be acquired 
with pulse sequence parameters that minimize the effect of signal relaxation. 
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 Introduction 
 Proton magnetic resonance spectroscopy (1H-MRS) in studies on the human brain requires 
relatively large voxels due to the low intensities of the metabolite signals. This poses a challenge for 
estimating metabolite concentrations in exclusively gray matter (GM) or white matter (WM) 
regions of interest (ROIs), since the voxels usually contain contributions from both GM and WM 
and, particularly in GM ROIs, cerebrospinal fluid (CSF). Several strategies exploiting spectroscopic 
imaging methods have been developed to estimate metabolite levels in pure GM or WM (1-7). 
However, these methods are not suitable to single voxel studies using conventional volume 
selection. The application of the many variations of these sequences, including popular spectral 
editing techniques that often require especially large voxels (8), by far dominates the use of 1H-
MRS in studies on the brain.  
 
  Although mixed tissue contributions present a potential confound for interpreting single 
voxel 1H-MRS of the brain, determining the composition of the voxel by segmentation of a co-
registered anatomical image allows correction for CSF, usually considered void of metabolites of 
interest at detectable levels, as well as the possibility of entering the tissue fraction of interest as a 
covariate in statistical analyses. Furthermore, if “absolute” concentrations are to be estimated, 
knowing the partial volume fractions allows the possibility of correcting for compartment-specific 
effects of relaxation on the observed signals (9-14). This is particularly important when using the 
water signal as a concentration standard since the water proton T1 and T2 relaxation times in GM, 
WM, and CSF differ markedly. Owing to the greater technical challenges of measuring the relaxation 
rates of metabolite signals (weak, overlapping, and often j-coupled), reports of their values have 
been inconsistent and, moreover, lacking for all metabolites of interest. However, when reported, 
the GM-WM differences have been small (reviewed by Di Costanzo et al. (15)). Consequently, these 
differences have been ignored in most studies reporting concentration estimates of 
neurometabolites. 
 
 A formula for estimating molal concentrations (moles/Kg of tissue water) of 
neurometabolites that incorporates the effects of compartment-specific relaxation on the water 
signal has been described (13). However, this formula does not account for tissue-specific effects of 
relaxation on metabolite signals but, instead, assumes that these rates are similar enough in GM and 
WM to incorporate them as a single factor. Here we extend the formula to include distinct 
metabolite relaxation terms and propose a similar equation for concentration estimates based on 
molarity (moles/L tissue). To our knowledge, an expression that correctly accounts for GM- and 
WM-specific metabolite relaxation in concentration estimates has not been previously reported. 
The modified equation necessarily contains two unknown variables and, as such, is not solvable 
explicitly. Nonetheless, it is useful for examining the impact of differing GM and WM metabolite 
relaxation rates on the estimate of metabolite concentrations over a range of MRS parameters and 
assumptions.  
 
Theory 
 Molality is concentration expressed in moles of solute per Kg of solvent. In brain tissue the 
solvent is water. The advantages of measuring molality in brain 1H-MRS experiments have been 
discussed in prior publications (13,14), and include insensitivity to temperature, barometric 
pressure, and the contribution of other solutes or non-soluble material to the solution. If the 1H-
MRS signals are acquire under fully relaxed conditions (TE<<T2, TR>>T1), the molality of the 
metabolite protons is directly proportional to the ratio of the metabolite signal intensity SM to the 
water signal intensity SH2O, without assumptions about the water density in the tissue as is required 
with molarity. In the simplest case of a 1H-MRS voxel sampling only pure GM or pure WM molality 
is given by:   
 
    [M]molal =
SM
SH2O
´
2
#HM
´[H2O]molal             [1] 
 
where [H2O]molal is the molality of pure water (55.49 moles/Kg water), #HM is the number of 
metabolite hydrogen atoms, 2 is the number of water protons, and both the water and metabolite 
fractions are assumed to be fully detected. If CSF is present in the voxel, the water signal is scaled 
by the tissue water mole fraction, fGM or fWM, or equivalently (1- fCSF), where fCSF is the CSF water 
mole fraction.  
 
 If the signals were not acquired under fully relaxed conditions, they must also be scaled by 
the appropriate T1- and T2-weighted relaxation factors. If the initial pulse angle is 90o in a double 
spin echo or stimulated echo type of experiment with equal echo spacing, this factor is Rx = exp[-
TE/T2x_y](1-exp[-TR/T1x_y]), where the subscript x refers to either the metabolite or water signal 
and y refers to the compartment (GM, WM, or CSF). While different protons on a metabolite can 
have different relaxation times, here we will assume that the times associated with the dominate 
peak approximately characterizes the entire signal (e.g. the N-acetyl peak of N-acetylaspartate). 
This is an important caveat, but one that could be avoided only with 1) knowledge of individual 
proton relaxation times which is, due to the difficulty of their measurement, lacking in the field, and 
2) an accurate modeling of the total signal from each metabolite that takes into account any 
differing relaxation attenuation among its various spectral peaks. In the general case of partial 
volume contributions from GM, WM, and CSF, each with a compartment-specific water proton 
relaxation factor (RH2O_GM, RH2O_WM, RH2O_CSF) but assuming a common GM and WM metabolite 
relaxation factor (RM), the molality is given by (13): 
 
 
[M]molal =
SM_obs´ (fGM´RH2O_GM  + fWM´RH2O_WM  + fCSF´RH2O_CSF)
SH2O_obs´ (1-fCSF)´RM
´
2
#HM
´[H2O]molal
      
[2] 
 
 The fractions in Eq. [2] are not the volume fractions estimated by image segmentation, but 
the mole fractions of water. They can be related to the volume fractions by taking into account the 
relative water fraction in each segmentation fraction: 
 
    [3] 
 
    [4] 
 
and 
    [5] 
 
where fGM_vol, fWM_vol, and fCSF_vol are the GM, WM, and CSF volume fractions, respectively, estimated by 
segmentation, and the density factors (d) are the water densities associated with them.  
 
 Accounting for tissue-specific metabolite signal relaxation in the equation for molality is 
analogous to accounting for compartment-specific water signal relaxation (13). However, a critical 
difference is that while the water molal concentration is the same in all compartments (i.e., the 
fGM= 
fGM_vol´dGM
fGM_vol´dGM + fWM_vol´dWM + fCSF_vol´dCSF
fWM= 
fWM_vol´dWM
fGM_vol´dGM + fWM_vol´dWM + fCSF_vol´dCSF
fCSF= 
fCSF_vol´dCSF
fGM_vol´dGM + fWM_vol´dWM + fCSF_vol´dCSF
concentration of water in pure water, 55.49 moles/Kg water) the metabolite concentrations are 
not. The metabolite mole fractions are not simply determined by the volume fractions and water 
tissue densities but also by the different metabolite concentrations in the GM and WM water 
fractions. The metabolite mole fractions, fM_GM and fM_WM, are related to the metabolite 
concentrations in GM and WM, [M]GM and [M]WM, respectively,  as   
  
         [6] 
and      
         [7] 
 
where the fractions fGM, fWM, and fCSF are the mole fractions of water given by Eqs. [3-5]. The 
observed metabolite signal is equal to the sum of the mole fractions of the fully relaxed signal SM_R , 
with each fractional signal weighted by its compartment-specific relaxation factor:  
 
    [8] 
 
Here R has been added to the subscript SM of Eq. [1] to emphasize that it is the total signal intensity 
(from all compartments) that would be observed under fully relaxed acquisition conditions. Solving 
for SM_R we obtain: 
 
         [9] 
 
 To account for the GM and WM metabolite signal fractions that are weighted by different 
relaxation factors, the term RM in Eq. [2] is substituted by the denominator of Eq. [9]. This term, 
which we label RM_GM_WM, can be expanded in terms of Eqs. [3], [4], [6], and [7]. Further, the 
unknown GM and WM concentrations can be expressed as a single ratio to obtain: 
 
        [10] 
fM_GM= 
fGM´[M]GM
fGM´[M]GM  + fWM´[M]WM
fM_WM= 
fWM´[M]WM
fGM´[M]GM  + fWM´[M]WM
SM_obs= fM_GM´SM_R´RM_GM + fM_WM´SM_R´RM_WM
SM_R =
SM_obs
fM_GM´RM_GM + fM_WM´RM_WM
RM_GM_WM =
fGM_vol´dGM´ ([M]GM/[M]WM)´RM_GM + fWM_vol´dWM´RM_WM
fGM_vol´dGM´ ([M]GM/[M]WM)  +  fWM_vol´dWM
 Inserting this term into Eq. 2 we obtain: 
 
       
[M]molal=
SM_obs´ (fGM´RH2O_GM + fWM´RH2O_WM + fCSF´RH2O_CSF)
SH2O_obs´ (1-fCSF)´RM_GM_WM
´
2
#HM
´[H2O]molal
         
[11] 
 
 Note that if the water and metabolite signals are acquired under fully relaxed conditions, 
Eq. [11] reduces to Eq. [1] with the water signal scaled by the tissue fraction, i.e., [M]molal is 
independent of the metabolite concentrations in each tissue. As with the water mole fractions, the 
metabolite mole fractions in the calculation of molality serve only to account for how much of the 
total metabolite signal is scaled by each compartment-specific relaxation factor. Hence, at very 
short TE and sufficiently long TR (when R~1), the observed signal is simply proportional to the 
number of moles of metabolite and tissue water in the voxel. Also, when the metabolite relaxation 
times are the same in GM and WM, Eq. [11] reduces to Eq. [2]. These results are expected, of course: 
under simplifying conditions, Eq. [11] must reduce to the simpler expressions. The validity of 
alternative strategies for including differing GM-WM metabolite relaxation rates in partial volume 
corrections (16,17) should also be evaluated with this requirement in mind. 
 
  An expression similar to Eq. [2] can be written for molarity (moles per volume of tissue) by 
taking into account that the fractional contribution to SH2O from each compartment is weighted not 
only by the compartment-specific relaxation terms when calculating moles per volume of tissue, but 
by the relative water densities in each compartment, as well. This effectively scales the molarity of 
water in pure water [H2O]molar (55.49 moles/L water) to the number of moles of water in the voxel 
volume. Again, starting with the simplest case of either pure GM or pure WM under fully relaxed 
conditions, molarity is given by: 
 
    [M]molar =
SM
SH2O
´  dtissue ´  
2
#HM
´[H2O]molar    [12] 
 
 In a voxel with a mixture of GM, WM, and CSF not sampled under fully relaxed conditions, 
the observed water signal SH2O_obs is the sum of the volume fractions of the fully relaxed signal SH2O_R 
from each compartment, with each fractional signal weighted by the relaxation factor and the water 
density of the compartment: 
 SH2O_obs= fGM_vol´dGM´SH2O_R´RH2O_GM  + fWM_vol´SH2O_R´dWM´RH2O_WM  + fCSF_vol´dCSF´SH2O_R´RH2O_CSF
              
            [13] 
 
 As with the derivation of Eq. [2], we solve for SH2O_R and substitute the resulting expression 
for SH2O in Eq. [12]. Assuming equal GM and WM metabolite signal relaxation times at this point, 
substituting SM_obs/RM for SM , and scaling SH2O by the tissue volume fraction to correct for the CSF 
inclusion yields:  
 
 
[M]molar =
SM_obs´ (fGM_vol´dGM´RH2O_GM + fWM_vol´dWM´RH2O_WM + fCSF_vol´dCSF´RH2O_CSF)
SH2O_obs´ (1-fCSF_vol)´RM
´
2
#HM
´[H2O]molar
  
            [14]  
 
  
 
 
where [H2O]molar is the molar concentration of pure water (55.49 moles/L).  
  
 To account for different metabolite signal relaxation rates in GM and WM, the term RM is 
replaced by RM_GM_WM to yield: 
 
[M]molar =
SM_obs´ (fGM_vol´dGM´RH2O_GM + fWM_vol´dWM´RH2O_WM + fCSF_vol´dCSF´RH2O_CSF)
SH2O_obs´ (1-fCSF_vol)´RM_GM_WM
´
2
#HM
´[H2O]molar
  
            [17]
 
 
Methods 
 Equations [11] and [17] contain two unknown variables: the total tissue (GM+WM) 
metabolite concentration [M] and the ratio of GM to WM metabolite concentrations (inherent in 
RM_GM_WM). As such, they cannot be solved explicitly. However, approximations of the GM/WM 
metabolite ratio for various metabolites in healthy or in diseased tissue can be obtained from many 
published reports. In most of these studies, spectroscopic imaging data was used to estimate 
concentrations in several voxels with mixed GM, WM, and CSF content. Hypothetically pure GM and 
WM concentrations were estimated by regressing the concentrations against the fractional GM 
content of the voxel, normalized by the total tissue fraction, and extrapolating to fractions of 0 and 
1 to estimate WM and GM concentrations, respectively(1). To demonstrate the impact of differing 
GM and WM metabolite T1 and T2 times on concentration estimates in the present report, we 
examine real and simulated spectroscopic imaging data, allowing us to display the effect over a 
range tissue compositions typically encountered in brain 1H-MRS.  
 
 Simulated data were generated with programs written with Matlab (version R2014A, The 
MathWorks Inc., www.matlab.com) by scaling hypothetical water and metabolite signals by the 
mole fractions and relaxation factors that would be associated with them in GM, WM, and CSF. The 
GM and WM molal concentrations assigned to the metabolite signal fractions were 18 and 15 
moles/Kg tissue water, respectively, drawing from previous work (18), with each signal attenuated 
by relaxation factors based on T1 and T2 times previously reported for the N-acetyl protons of N-
acetylaspartate (NAA) in GM and WM (19). (See the caption for Fig. 1 for more details.) To better 
mimic the situation of a slice transecting the inter-hemispheric fissure, an increasing fraction of CSF 
was included in the hypothetical voxels after the GM fraction exceeds the WM fraction, reaching a 
maximum of 15% when the WM is zero. In other words, voxels with no WM have 85% GM and 15% 
CSF, reflecting the common overlap of predominantly GM voxels with CSF spaces. Molal 
concentrations are plotted versus normalized GM mole fraction (fGM/fGM+fWM) and molar 
concentrations versus the normalized GM volume fraction (fGM_vol/fGM_vol+fWM_vol).  
 
 NAA measurements were obtained from a healthy human subject in a previously reported 
study (18). Briefly, MRI anatomical and spectroscopic imaging data were acquired with a Siemens 
3T Tim Trio scanner. 1H-MRS imaging was performed with a phase-encoded version of a double 
spin echo sequence, both with and without water presaturation (TE = 40 ms, TR = 1500 ms, slice 
thickness = 15mm, FOV = 220 x 220 mm, circular k-space sampling (radius = 12), total scan time = 
582s). The MRS data were initially analyzed with LCModel (http://s-provencher.com) and then 
with Matlab programs that applied either Eqs. [11] or [17]. GM, WM, and CSF segmentaion maps 
were generated from a T1-weighted MPRAGE image using SPM5 
(http://www.fil.ion.ucl.ac.uk/spm). The study was conducted with the approval of the Institutional 
Review Board of the University of New Mexico Health Sciences Center. 
 
Results   
 To illustrate the effect of differing GM and WM metabolite relaxation times, we show only 
the case of molal concentrations, since the term RM_GM_WM is a scaling factor that will affect the 
molarity and molality expressions similarly. To this end, the GM-WM averaged T1 and T2 metabolite 
times in Eq. [11] were replaced by the tissue-specific times reported in reference 19 (T1GM_NAA = 1.47 
s, T1WM_NAA = 1.35 s, T2GM_NAA = 247 ms, T2WM_NAA = 295 ms). Data were simulated for 5 sets of TR and 
TE times: TE/TR = 0.006/3 s, TE/TR = 0.006/2 s, TE/TR = 0.006/1.5 s, TE/TR = 0.020/1.5 s, and 
TE/TR = 0.040/1.5 s. For comparison, data were also simulated with a single average T1 and T2 for 
both GM and WM. The plots of these data are shown in Fig. 1. Along the bold line are overlaid the 
plots of data corrected with Eq. [11] using the correct relaxation times across the range of TE and 
TR, yielding the correct results in each case. The thinner lines that deviate from the bold line 
illustrate the errors that arise when using the same averaged T1 and T2 values for both GM and WM 
signals. As expected, the error increases at longer TE and shorter TR and with a greater fraction of 
either WM or GM. This error ranged from approximately 1.6% (TE/TR = 0.006 s/3 s) to 3.7% 
(TE/TR = 0.040 s/1.5 s) in the estimate of the concentration in either pure WM or GM.  This trend 
will continue, of course, as TE lengthens and/or TR becomes shorter, which can be verified simply 
by examining the case of either a pure GM or a pure WM voxel. For example, assuming the 
relaxations times used here for the example of NAA and a TR of 1.5 s and a TE of 144 ms, 
adjustment with a single tissue-averaged metabolite relaxation term would produce an estimate 
of pure GM NAA concentration that would be 7.8% lower than the estimate using tissue-specific 
relaxation times. In pure WM, this estimate would be 6.5% higher than the estimate using tissue-
specific relaxation times. At TE = 0.006 s and TR = 6 s, ,on other hand, the maximum errors will be 
less than 0.5%.  
 
 Estimating absolute metabolite concentrations while accounting for compartment-specific 
GM and WM signal relaxation times requires an assumption about the GM/WM metabolite ratio in 
order to assign each fraction of the total metabolite signal to its distinct relaxation factor. The 
dotted line in Fig. 2 illustrates the error in the concentration estimate when there is an error in this 
ratio. For the representative case shown, the corrected data were simulated with TE=40 ms and 
TR=1.5 s. The dotted line shows the deviation from the correct concentrations when the GM/WM 
metabolite ratio is assumed to be 1.5 rather then the correct ratio of 1.2 (18/15). The errors in the 
concentrations will depend not only on the error in the ratio but on the tissue composition and 
assumed relaxation times. The error will be zero for voxels containing only WM or only GM and CSF 
and will be maximal at an intermediate mix of GM and WM. For the example shown the maximum 
error was less than 0.5%. 
 
***Fig. 2 appears near here*** 
 
 Illustrated in Fig. 2A is the application of Eqs. [11] and [17] to NAA measurements obtained 
from a healthy human subject with TE=40 ms and TR=1.5 s and corrected using the averaged T1 
and T2 values for GM and WM used in the simulations. The regression plots of the corrected NAA 
concentrations versus normalized GM fraction demonstrate the basic differences between molarity 
and molality illustrated by the simulated data.   
 
 In Fig. 2B, the same raw data are plotted after correction with Eq. [11] assuming different 
metabolite signal T1 and T2 values in GM and WM (the same values used in the simulation) and a 
GM/WM NAA concentration ratio of 1.3. The latter factor was derived from the regression involving 
the data corrected with the same, averaged T1 and T2 times for both GM and WM (shown in Fig. 2A). 
Notable is the lower WM and higher GM extrapolated endpoints of the regression relative to the 
endpoints of the regression involving the molal data shown in Fig. 2A. The “100% WM” endpoint is 
3.7% lower and the “100% GM” endpoint is 3.8% higher than these values when assuming single, 
averaged T1 and T2 values in both tissues, resulting in a higher GM/WM metabolite concentration 
ratio estimate of 1.4. This is similar to the results obtained in the simulated data analysis when the 
data were generated with TE=40 ms and TR=1.5 s and tissue-specific relaxation times were used 
rather than tissue-averaged times (bold line versus thin line for TE/TR = 0.04/1.5s in Fig. 1). The 
sum of the square residuals of the linear regression shown in Fig. 2A was within 0.1% of the sum of 
the square residuals of the linear regression shown in Fig. 2B. Hence, no improvement in the fit of 
the data to a straight line was observed when using tissue-specific relaxation factors to adjust the 
data in this case. To explore the possibility of converging toward a stable value for the metabolite 
ratio with an iterative application of Eq. [11], the analysis was repeated assuming a GM/WM 
metabolite ratio of 1.4, but without a substantial change (<0.1%) in the results.  
 
Discussion 
 The reliable estimation of neurometabolite concentrations by 1H-MRS is faced with 
numerous challenges (20), not the least of which is the heterogeneity of the tissue within the voxel. 
To simplify this problem, it is generally assumed that the sampled brain region is composed of only 
three compartments - GM, WM, and CSF – and, at times, a fourth compartment encompassing an 
MRI-detectable lesion. Each of these compartments is likely to have not only a different metabolite 
concentration and water density, but also different relaxation times associated with the signals. In a 
previous report, we presented Eq. [2] for adjusting molal concentration estimates for partial 
volume and water signal relaxation effects (13). We also examined the impact of errors arising from 
estimates of the relative fractions of GM, WM, and CSF in the voxel (segmentation errors) as well as 
errors in the water signal relaxation times associated with those fractions. In the present report, we 
extend Eq. [2], along with a similar equation for estimating molarity, to account for tissue-specific 
metabolite signal relaxation. To our knowledge, this is the first valid expression presented for 
accomplishing this. In view of alternative methods that have been proposed for performing this 
correction (16,17), it is worth emphasizing that scaling only the GM and WM volume or water 
fractions by the distinct metabolite relaxation factors is not equivalent to scaling the GM and WM 
metabolite signal fractions by these factors. In order to calculate the size of the latter signal 
fractions, the relative metabolite concentrations in GM and WM must be known or assumed. 
Furthermore, any valid expression for correcting for metabolite signal relaxation differences must 
reduce to the simpler valid equations under simplifying conditions, such as when the observed 
signals are fully relaxed or when there is only a single tissue type in the voxel.  
 
 We analyzed the case of just one metabolite (NAA) at a field strength of 3T in this work, 
assuming relaxation times previously reported for that metabolite at 3T. These results, of course, 
can be extended to any metabolite under different sets of assumptions with respect to partial 
volume fractions, tissue concentrations, relaxation rates, and pulse parameters: the general trends 
in errors resulting from ignoring differences in tissue specific relaxation rates, or assuming 
inaccurate values, will be the same. Since the principle factor underlying these errors will be the 
difference in GM and WM metabolite relaxation times, knowledge of these times is essential to 
correcting for them accurately. Unfortunately, such information is lacking for most metabolites 
across the wide range of magnetic field strengths currently in use for brain studies, and few studies 
have attempted to measure the relaxation times of the various distinct proton signals that make up 
a metabolite spectrum. Adding to this uncertainty, metabolite relaxation times have been shown to 
vary with age, pathology, and brain region (21-24; and, given that metabolite T2 times appear to 
shorten with increasing field strength (25-29) while T1 times may lengthen (28,29), the sensitivity 
to TE and TR times is expected to increase at higher fields. 
 
 In the case of NAA at 3T, we estimate that when tissue-averaged relaxation times are used 
for GM and WM instead of tissue-specific relaxation times, errors of a few percent arise over the 
range of representative TE and TR values examined. These errors, of course, are maximal in pure 
GM and pure WM voxels and could be predicted based on the differing GM and WM relaxation rates 
alone. However, in voxels with mixed tissue composition, the full expression (Eq. 11) is needed to 
estimate the effects of tissue-specific relaxation. This entails that the relative metabolite 
concentrations in each compartment are assumed since, when dealing with real data, they are not 
known a priori.  Reasonable assumptions about GM and WM metabolite concentrations might be 
obtained from prior estimates, for example, from multi-voxel studies in which the fractional signals 
were assumed to relax with common T1 and T2 times. In the present report, we adjusted NAA 
spectroscopic imaging data with different GM and WM NAA signal relaxation times using Eq. [11] 
and a GM/WM NAA ratio obtained from a prior analysis in which equivalent tissue-averaged GM 
and WM relaxation times were assumed. Repeating the tissue-specific analysis with the 
concentration ratio obtained in the prior analysis did not substantially alter the results (<0.1%). We 
note that this approach would not be feasible in single voxel studies; and, hence, assumptions about 
the GM/WM concentration ratio for any metabolite would be an important caveat in the 
interpretation of the results, particularly in studies on pathological tissue or differing regions of the 
brain. Though the errors in GM or WM metabolite concentration estimates are small in the 
simulated and real data analyses of this report, they nonetheless introduced a measurable analysis 
bias in the results.  
 
 To address the issue of tissue-specific water signal relaxation, a method was proposed to 
measure brain water signal relaxation and density differences on a voxel-by-voxel basis by 
acquiring in situ water relaxation and density maps along with 1H-MRS imaging data (31). 
However, while reliably measuring the relaxation rates of the large water signal can be 
accomplished with straightforward imaging techniques, in situ GM and WM metabolite signal 
relaxation measurements are prohibitively time-consuming, technically challenging and, hence, 
impractical in a clinical setting. Given this impracticality, the most straightforward approach for 
improving the accuracy of absolute concentration estimates is simply to use acquisition parameters 
that minimize the impact of signal relaxation as much as possible, a remedy that has long been 
recommended to improve the accuracy of MRS concentration estimates. Minimizing T2 effects has 
become feasible with the advent of ultra-short-TE sequences (24,32,33), while acquiring the water 
signal with a small pulse angle (24) reduces the impact of water signal T1 differences. Small pulse 
angles, unfortunately, are not practical for the acquisition of metabolite signals, and lengthening TR 
comes at a cost increasing the total acquisition time. For the example of the NAA signal and 
assumed relaxation times at 3T used in this report, we estimate the errors to be as large as 8% 
when TE= 144 ms and TR=1.5 s but less than 1% when tissue-averaged rather than tissue-specific 
relaxations are used for partial volume correction of data acquired with TE= 6 ms and TR=6 s. 
 
 In summary, the brain tissue milieu sampled by a typical MRS voxel is complex, conferring 
different MR properties on the detected signals depending on the cellular or extracellular 
compartment of origin. In order to interpret these signals in a practical manner, simplifying 
assumptions need to be made. In this report we present an extension of our earlier expression for 
correcting for partial volume effects in 1H-MRS data from the brain assuming three compartments: 
GM, WM, and CSF. The fuller expression accounts for tissue-specific metabolite signal relaxation 
and requires assumptions not only with respect to the relaxation times, but with respect to the 
relative metabolite concentrations in GM and WM. With simulated data, we demonstrate the 
magnitude of the errors that arise when there are differences in GM and WM metabolite signal 
relaxation times that are not taken into account or when incorrect assumptions about the GM/WM 
concentration ratio are made. Given the substantial technical challenges of reliably measuring 
metabolite signal relaxation in situ, the simplest approach to reducing these errors is to acquire the 
data with pulse sequence parameters that minimize the effect of relaxation on the signal. 
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Figure Captions 
 
Figure 1. Errors due to assuming average T1 and T2 values for the metabolite averaged across GM 
and WM (thin solid lines) rather than using distinct tissue specific relaxation values (thick line). 
Metabolite axis ([M]) units are moles/Kg water and x-axis units are normalized gray matter water 
mole fractions (fGM/fGM+fWM). We assume that the water signal is characterized by the following 
parameters: CSF T1/T2 = 4 s/2.55 s; GM T1/T2 = 1.304 s/0.11 s; WM T1/T2 = 0.830/0.080 s (specific 
sources cited in reference 18); CSF/GM/WM water density = 0.97/0.78/0.65 (9). Raw data were 
simulated with the metabolite GM T1/T2 = 1.47 s/0.247 s and the metabolite WM T1/T2 = 1.35 
s/0.295 s, reported for the N-acetyl protons of NAA (19). Eq. [11] was used to adjust the raw data, 
assuming either the latter tissue-specific T1 and T2 values or GM-WM averaged T1 and T2 values 
(T1= 1.41 s and T2= 271 ms for both GM and WM). This was done for a range of TEs and TRs: 0.04 
s/1.5 s, 0.02 s/1.5 s, 0.006 s/1.5 s, 0.006 s/2.0 s, 0.006 s/3.0 s. The thick line terminating at 15 
moles/Kg tissue water and 18 moles/Kg tissue water is the plot of the adjusted data when the 
tissue-specific values are used in Eq. [11] for any of the tested TE and TR combinations (i.e., lines 
for all 5 sets overlap). The thinner lines show increasing deviations from the thick (correct) line 
with increasing TE or decreasing TR (i.e., maximum deviation with TE/TR= 0.04 s/1.5 s, minimum 
deviation for with TE/TR= 0.006 s/3.0 s). 
 
Figure 2. Raw Data simulated with GM/WM metabolite ratio equal to 1.2 and adjusted assuming 
either a ratio1.2 (solid line) or a incorrect ratio of 1.5 (dotted line). 
 
Figure 3. A. 1H-MRS imaging NAA data from a supraventricular slab in the brain of a healthy 
subject. Circles: Data before adjustment for partial volume and relaxation effects. Diamonds: Molal 
concentrations (moles/Kg tissue water) adjusted with Eq. [2]. See text for details. B. Molal 
concentrations based on data displayed in Fig 2A. adjusted with Eq. [11] for distinct GM and WM 
relaxation times. See text for details. 
